Breaking News Instant updates and real-time market news.

AMRN

Amarin

$3.01

-0.02 (-0.66%)

08:25
04/09/18
04/09
08:25
04/09/18
08:25

Amarin risk/reward favorable into Q3 data, says Jefferies

Jefferies analyst Matthew Andrews surveyed 50 U.S. physicians and high prescribers of Amarin's Vascepa to assess current use of Vascepa in mixed dyslipidemia and severe high triglycerides, and future prescribing habits based on the REDUCE-IT data. The survey indicates Vascepa is the leading triglycerides-lowering drug in severe hypertriglyceridemia and mixed dyslipidemia, and positive MACE data in the REDUCE-IT trial could increase use 125% and 50%, respectively, Andrews tells investors in a research note. The analyst estimates peak-adjusted U.S. Vascepa sales of $1.06B by 2030. He sees a favorable risk/reward on Amarin shares into the Q3 data. The stock has upside to $7 on positive data and downside to $2.25 on a negative readout, Andrews contends. He keeps a Buy rating on Amarin with a $7 price target.

AMRN Amarin
$3.01

-0.02 (-0.66%)

03/01/18
HCWC
03/01/18
NO CHANGE
Target $10
HCWC
Buy
Amarin has 'significant upside' on positive trial data, says H.C. Wainwright
H.C. Wainwright analyst Andrew Fein continues to believe that Amarin's current valuation is supported by Vascepa sales alone. The potential success of the Reduce-It trial represents "significant upside," Fein tells investors in a research note. He reiterates a Buy rating on Amarin with a $10 price target following the company's Q4 results.
02/20/18
CANT
02/20/18
NO CHANGE
Target $10
CANT
Overweight
Amarin shares compelling ahead of data, Cantor Fitzgerald
Amarin shares represent a "compelling investment opportunity" ahead of data for the company's Reduce-It study before the end of Q3, Cantor Fitzgerald analyst Louise Chen wrote Friday in a research note to investors. She expects the data to be positive. Amarin recently raised $70M and could raise up to another $10.5M gross, if overallotment is exercised, ahead of the data readout which removes a financing overhang and accelerates the company's plan to expand its sales and promotion of Vascepa, Chen argues. She keeps an Overweight rating on the shares with a $10 price target.
01/23/18
CANT
01/23/18
NO CHANGE
Target $10
CANT
Overweight
Amarin shares have room to run ahead of data, says Cantor Fitzgerald
Cantor Fitzgerald analyst Louise Chen views this morning's announcement from Amarin as good news since the company is on track to report top-line results from the study before the end of Q3. Amarin this morning announced that its Reduce-It cardiovascular outcomes study has reported and documented more than 90% of the targeted 1,612 primary major adverse cardiovascular events. The analyst believes the shares have to room to run ahead of the data release. She keeps an Overweight rating on the name with a $10 price target.
01/05/18
CANT
01/05/18
NO CHANGE
Target $10
CANT
Overweight
Cantor sees Amarin as top performing stock in 2018
Cantor Fitzgerald analyst Louise Chen says Amarin's preliminary 2017 results and 2018 outlook underscore her view that the company will be one of the top performing stocks in her coverage universe this year. Revenue growth is being driven by increased prescriptions for Vascepa capsules, Chen tells investors in a research note titled "AMRN Remains One of Our Top Catches of The Year." She believes the REDUCE-IT study results in 2018 will be positive and keeps an Overweight rating on the shares with a $10 price target.

TODAY'S FREE FLY STORIES

09:30
04/26/18
04/26
09:30
04/26/18
09:30
General news
Breaking General news story  »

Week of 4/22 Bloomberg…

UPS

UPS

, AMZN

Amazon.com

09:29
04/26/18
04/26
09:29
04/26/18
09:29
Hot Stocks
UPS says relationship with Amazon.com 'mutually beneficial' »

Says company's…

UPS

UPS

AMZN

Amazon.com

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 26

    Apr

  • 27

    Apr

TER

Teradyne

09:28
04/26/18
04/26
09:28
04/26/18
09:28
Recommendations
Teradyne analyst commentary  »

Teradyne price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

  • 30

    May

AMEH

Apollo Medical

09:25
04/26/18
04/26
09:25
04/26/18
09:25
Initiation
Apollo Medical initiated  »

Apollo Medical initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 18

    Jun

HLX

Helix Energy

09:23
04/26/18
04/26
09:23
04/26/18
09:23
Upgrade
Helix Energy rating change  »

Helix Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

BAYRY

Bayer

, MON

Monsanto

09:23
04/26/18
04/26
09:23
04/26/18
09:23
Periodicals
Bayer-Monsanto deal on track for U.S. approval by May, Reuters reports »

Bayer (BAYRY) is on track…

BAYRY

Bayer

MON

Monsanto

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 08

    May

  • 18

    May

BA

Boeing

09:22
04/26/18
04/26
09:22
04/26/18
09:22
Recommendations
Boeing analyst commentary  »

Boeing price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

SIEGY

Siemens

09:22
04/26/18
04/26
09:22
04/26/18
09:22
Hot Stocks
Siemens names Barbara Humpton as CEO for the U.S., effective June 1 »

Siemens Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 21

    May

USG

USG

09:21
04/26/18
04/26
09:21
04/26/18
09:21
Hot Stocks
USG sends letter to stockholders in response to Knauf »

USG Corporation filed an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EBAY

eBay

09:20
04/26/18
04/26
09:20
04/26/18
09:20
Recommendations
eBay analyst commentary  »

eBay post-earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

THR

Thermon Group

09:19
04/26/18
04/26
09:19
04/26/18
09:19
Upgrade
Thermon Group rating change  »

Thermon Group upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

AMD

AMD

09:19
04/26/18
04/26
09:19
04/26/18
09:19
Hot Stocks
AMD says working with number of unannounced data center clients »

AMD CEO Lisa Su is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

SPX

S&P 500

, VIX

Volatility Index S&P 500 Options

09:18
04/26/18
04/26
09:18
04/26/18
09:18
Options
Overnight activity included 235 trades in SPX and 3 trades in VIX »

235 trades were executed…

SPX

S&P 500

VIX

Volatility Index S&P 500 Options

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HES

Hess Corp.

09:17
04/26/18
04/26
09:17
04/26/18
09:17
Downgrade
Hess Corp. rating change  »

Hess Corp. downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

UPLD

Upland Software

09:17
04/26/18
04/26
09:17
04/26/18
09:17
Hot Stocks
Upland Software partners with Thavron Solutions for IT management »

Upland Software announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 29

    May

  • 12

    Jun

BKU

BankUnited

09:17
04/26/18
04/26
09:17
04/26/18
09:17
Upgrade
BankUnited rating change  »

BankUnited upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UPS

UPS

09:17
04/26/18
04/26
09:17
04/26/18
09:17
Hot Stocks
Breaking Hot Stocks news story on UPS »

UPS says confident a deal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

COP

ConocoPhillips

09:17
04/26/18
04/26
09:17
04/26/18
09:17
Downgrade
ConocoPhillips rating change  »

ConocoPhillips downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 07

    May

  • 22

    May

  • 30

    May

ABBV

AbbVie

09:16
04/26/18
04/26
09:16
04/26/18
09:16
Hot Stocks
Breaking Hot Stocks news story on AbbVie »

AbbVie says 'highly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 27

    Apr

  • 08

    May

  • 21

    May

  • 05

    Jun

AAL

American Airlines

09:16
04/26/18
04/26
09:16
04/26/18
09:16
Hot Stocks
Breaking Hot Stocks news story on American Airlines »

American Airlines: EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 26

    Jun

PLUS

ePlus

09:16
04/26/18
04/26
09:16
04/26/18
09:16
Hot Stocks
ePlus ePlus announces 500,000 share stock repurchase program »

ePlus announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCO

Taubman Centers

09:15
04/26/18
04/26
09:15
04/26/18
09:15
Hot Stocks
Land & Buildings sends letter to Taubman Centers shareholders »

Land & Buildings sent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

RTN

Raytheon

, LMT

Lockheed Martin

$329.23

-7.14 (-2.12%)

09:15
04/26/18
04/26
09:15
04/26/18
09:15
Recommendations
Raytheon, Lockheed Martin, General Dynamics, Northrop Grumman analyst commentary  »

Defense weakness due to…

RTN

Raytheon

LMT

Lockheed Martin

$329.23

-7.14 (-2.12%)

GD

General Dynamics

$214.53

-7.51 (-3.38%)

NOC

Northrop Grumman

$333.06

-7.94 (-2.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 30

    May

ALGT

Allegiant Travel

$143.35

-0.1 (-0.07%)

09:15
04/26/18
04/26
09:15
04/26/18
09:15
Upgrade
Allegiant Travel rating change  »

Allegiant Travel upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COLB

Columbia Banking

$44.76

0.05 (0.11%)

09:14
04/26/18
04/26
09:14
04/26/18
09:14
Earnings
Columbia Banking reports Q1 EPS 55c, consensus 65c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 12

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.